Citeline Podcasts

OxSonics Hopes To Use Ultrasound To Enhance Drug Efficacy – Without Reformulation by Citeline

Citeline managing editor Brain Yang discusses with Insilico Co-CEO and Head of Drug Discovery Feng Ren on artificial intelligence-assisted drug discovery for idiopathic pulmonary fibrosis.

https://scrip.pharmaintelligence.informa.com/SC147940/AI-ChatGPT-And-The-Future-Of-Drug-Discovery-China-Biotech-CEO-Podcast-WIth-Insilicos-CoCEO

This podcast is the second installment of the conversation between Citeline and Quest Diagnostics.

This conversation explores the challenges sponsors face when identifying trial sites and principal investigators and the importance of identifying the right sites and principal investigators for clinical trials.

This podcast explores the challenges sponsors face when identifying trial sites and principal investigators and the importance of identifying the right sites and principal investigators for clinical trials.

China’s Akeso has made a name for itself on the world stage by cutting a potential $5bn licensing deal with US biotech Summit in December 2022. Michelle Xia, founder, chairwoman and CEO of the biopharma, is beginning to look beyond the deal, describing it one of the first steps for Akeso to develop and commercialize innovative drugs globally on its own.

Time marks:

Introduction

Licensing deal with Summit Therapeutics (00:20)

Latest progress of the partnership (01:33)

Ivonescimab’s potential breakthrough (03:21)

Akeso’s journey (04:51)

Platform buildup and choice of targets (07:22)

Cadonilimab versus PD-1 (11:32)

Licensing prospects of cadonilimab (14:43)

Bispecific antibody versus ADC (17:10)

Rationale behind deal-making (19:50)

Go global on its own (22:20)

Closing

Akeso's Xia Looks Beyond Summit Deal To Independent Global Development, Sales:

https://scrip.pharmaintelligence.informa.com/SC147939/Akesos-Xia-Looks-Beyond-Summit-Deal-To-Independent-Global-Development-Sales

In this episode, HBW Insight catches up with director general of the Association of the European Self-Care Industry, Jurate Švarcaite, to find out about the association’s upcoming Annual Meeting. Taking place in Paris, France, between the 22nd and 24th May, the meeting begins with a networking cruise along the river Seine and ends with a series of participatory workshops on key and trending topics like probiotics, Rx-to-OTC switch and sustainability. Along the way, delegates will hear from insiders and experts on how the new EU pharmaceutical legislation and a raft of incoming environmental regulations will impact the region’s self-care sector. Attendees will also find out about how consumers and industry leaders are shaping the future of Europe’s consumer healthcare sector.

https://scrip.pharmaintelligence.informa.com/SC147933/Quick-Listen-Scrips-Five-MustKnow-Things

Quick Listen: Scrip’s Five Must-Know Things:

https://scrip.pharmaintelligence.informa.com/SC147899/Quick-Listen-Scrips-Five-MustKnow-Things

Pink Sheet reporters and editors discuss the impact of PhRMA’s new push to limit Medicare price negotiations, Congress’ interest in FDA advisory committee reforms, and concerns about the COVID-19 vaccine strain selection process.

Announcing the 2nd Citeline Pharma Intelligence Awards Japan, which will take place in Tokyo on 17 October. Entries are now open with a deadline of 10 July. Check out the links below for all the information on categories, judges, how to enter, table bookings and sponsorship opportunities. See you in Tokyo!

English-language event site is here:

https://pharmaintelligence.informa.com/citelinepharmaintelligenceawards2023

Japanese-language event site is here:

https://pharmaintelligence.informa.com/ja-jp/citelinepharmaintelligenceawards2023

https://scrip.pharmaintelligence.informa.com/SC147763/Citeline-Pharma-Intelligence-Awards-Japan-2023-Entries-Now-Open